We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.78%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$17.4B
AUM Growth
+$1.04B
(+6.3%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
0.7%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
1,119
New
175
Increased
316
Reduced
445
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$176M |
| 2 |
Airbnb
ABNB
|
+$145M |
| 3 |
Mastercard
MA
|
+$132M |
| 4 |
Edwards Lifesciences
EW
|
+$120M |
| 5 |
Marathon Petroleum
MPC
|
+$92.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$210M |
| 2 |
HCA Healthcare
HCA
|
+$203M |
| 3 |
O'Reilly Automotive
ORLY
|
+$150M |
| 4 |
Expeditors International
EXPD
|
+$91M |
| 5 |
Adobe
ADBE
|
+$78.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.35% |
| 2 | Consumer Discretionary | 13.64% |
| 3 | Healthcare | 12.96% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
PRA Group
PRAA
$683M
| $7.23M | 0.04% |
+316,419
| New | +$8.77M |
|
|
MRC
327
DELISTED
MRC Global
MRC
| $7.17M | 0.04% |
711,942
-137,202
| -16% | -$1.3M |
|
|
MRTX
328
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.06M | 0.04% |
195,320
+10,604
| +6% | +$437K |
|
|
BPMC
329
DELISTED
Blueprint Medicines
BPMC
| $7.05M | 0.04% |
111,531
-15,321
| -12% | -$833K |
|
330
Ginkgo Bioworks
DNA
$487M
| $6.92M | 0.04% |
93,001
-76,074
| -45% | -$4.5M |
|
|
BLUE
331
DELISTED
bluebird bio
BLUE
| $6.88M | 0.04% |
104,546
+36,950
| +55% | +$2.7M |
|
|
NVRO
332
DELISTED
NEVRO CORP.
NVRO
| $6.8M | 0.04% |
267,641
-14,234
| -5% | -$411K |
|
333
GoodRx Holdings
GDRX
$1.03B
| $6.67M | 0.04% |
1,208,678
+170,514
| +16% | +$918K |
|
334
Universal Insurance Holdings
UVE
$1.21B
| $6.66M | 0.04% |
431,531
+52,739
| +14% | +$874K |
|
335
Unum
UNM
$13.8B
| $6.61M | 0.04% |
138,574
-5,912
| -4% | -$258K |
|
|
PRA
336
DELISTED
ProAssurance
PRA
| $6.61M | 0.04% |
437,963
-46,374
| -10% | -$730K |
|
337
Domo
DOMO
$161M
| $6.61M | 0.04% |
450,632
-3,356
| -0.7% | -$49.6K |
|
338
MasterCraft Boat Holdings
MCFT
$602M
| $6.5M | 0.04% |
211,945
-51,135
| -19% | -$1.48M |
|
|
ITOS
339
DELISTED
iTeos Therapeutics
ITOS
| $6.49M | 0.04% |
490,380
-24,545
| -5% | -$350K |
|
340
TG Therapeutics
TGTX
$8.53B
| $6.46M | 0.04% |
259,951
| – | – |
|
341
iShares Russell 2000 Growth ETF
IWO
$14.4B
| $6.45M | 0.04% |
26,600
-9,800
| -27% | -$2.25M |
|
342
Associated Banc-Corp
ASB
$5.78B
| $6.41M | 0.04% |
395,239
-141,577
| -26% | -$2.33M |
|
343
Credo Technology Group
CRDO
$38.8B
| $6.39M | 0.04% |
+368,382
| New | +$4.38M |
|
344
iShares Russell 1000 Growth ETF
IWF
$120B
| $6.36M | 0.04% |
92,400
-36,400
| -28% | -$2.31M |
|
|
CCRN
345
DELISTED
Cross Country Healthcare
CCRN
| $6.35M | 0.04% |
226,189
-642,750
| -74% | -$16M |
|
|
MRO
346
DELISTED
Marathon Oil Corporation
MRO
| $6.35M | 0.04% |
275,806
-305,728
| -53% | -$7.2M |
|
347
CoreCivic
CXW
$3.09B
| $6.33M | 0.04% |
672,497
-90,150
| -12% | -$818K |
|
348
Hyster-Yale Materials Handling
HY
$596M
| $6.28M | 0.04% |
112,547
-3,869
| -3% | -$198K |
|
349
Powell Industries
POWL
$7.99B
| $6.28M | 0.04% |
310,989
+31,152
| +11% | +$540K |
|
350
AT&T
T
$167B
| $6.24M | 0.04% |
+390,953
| New | +$6.66M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2023 Portfolio in Review
As of Q2 2023, Jacobs Levy Equity Management held 1,119 positions worth $17.4B, up 6.3% from $16.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jacobs Levy Equity Management's Q2 2023 filing shows 175 new, 316 increased, 445 reduced and 162 closed positions. Its largest new stake was Airbnb: 1,241,173 shares worth $159M. The largest sale was Netflix, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jacobs Levy Equity Management's largest Q2 2023 buy was Airbnb: 1,241,173 shares worth $159M.
- Jacobs Levy Equity Management added most to Humana in Q2 2023, an estimated $176M increase.
- Jacobs Levy Equity Management's biggest Q2 2023 reduction was Netflix, cutting an estimated $210M.
- Jacobs Levy Equity Management fully exited HCA Healthcare in Q2 2023, selling an estimated $203M.
- Jacobs Levy Equity Management's ten largest holdings make up 21% of its $17.4B portfolio in Q2 2023.
- Jacobs Levy Equity Management opened 175 new positions and closed 162 in Q2 2023.
- Jacobs Levy Equity Management's portfolio value rose 6.3% quarter-over-quarter to $17.4B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2023, filed 14 Aug 2023.